The Cardiac Profile B test is an advanced diagnostic blood panel utilized to comprehensively assess cardiovascular disease risk and evaluate overall heart health. Beyond standard cholesterol measurements, this extensive panel often evaluates specialized biomarkers such as high-sensitivity C-reactive protein (hs-CRP) for inflammation, homocysteine levels, and specific cardiac risk indicators. By identifying hidden arterial inflammation, metabolic imbalances, and early signs of plaque buildup, the Cardiac Profile B test provides physicians with critical data. This empowers patients and healthcare providers to implement targeted preventative interventions, personalize treatment strategies, and effectively lower the long-term risk of heart attacks and strokes.

The Cardiac Profile A test is a comprehensive blood panel designed to evaluate heart health and assess the risk of cardiovascular disease. This screening typically measures key biomarkers such as a lipid profile (including total cholesterol, HDL, LDL, and triglycerides) and fasting blood glucose to detect early warning signs of heart conditions, atherosclerosis, and diabetes-related risks. By providing clear insights into your metabolic and lipid status, this essential diagnostic test empowers you and your healthcare provider to proactively manage heart health, implement lifestyle changes, and prevent future cardiac complications effectively.

A calcium test is a simple blood test that measures the total amount of calcium circulating in your bloodstream. Calcium is a vital mineral essential for building strong bones and teeth, supporting nerve function, regulating muscle contraction, and maintaining normal heart rhythm. Doctors commonly order this test as part of a routine metabolic panel to evaluate overall health or to investigate symptoms related to bone disorders, kidney disease, or parathyroid gland issues. Both abnormally high and low levels can indicate underlying medical conditions, helping healthcare providers diagnose, monitor, and effectively guide your treatment plan.

A fasting C-peptide test is a valuable blood diagnostic assay used to measure the level of C-peptide in the bloodstream after a period of fasting. C-peptide is a byproduct created when proinsulin splits into insulin and C-peptide in equal amounts. Because it is secreted in tandem with endogenous insulin, measuring fasting C-peptide helps healthcare providers evaluate how much natural insulin the pancreas is actively producing. This test is essential for differentiating between type 1 and type 2 diabetes, assessing insulinoma tumors, and monitoring pancreatic function in patients managing diabetes treatment plans effectively.

The Bullous Pemphigoid 230 (BP230) test is a specialized diagnostic immunoassay designed to detect circulating autoantibodies directed against the BP230 protein, which is an essential structural component of hemidesmosomes in the skin. This blood test is crucial for evaluating vesiculobullous disorders, particularly in diagnosing autoimmune blistering conditions like bullous pemphigoid. By identifying these specific antibodies, clinicians can differentiate BP from other similar blistering skin diseases. Measuring BP230 antibody levels helps confirm clinical diagnoses, evaluates the underlying immune response, and assists healthcare providers in monitoring disease activity and therapeutic effectiveness over time.

The Bullous Pemphigoid 180 (BP180) serum test is a specialized diagnostic blood assay used to detect specific autoantibodies targeting the BP180 protein. This protein plays a critical role in maintaining skin structural integrity. The test evaluates vesiculobullous disorders, helping physicians accurately diagnose autoimmune blistering conditions like bullous pemphigoid, which cause painful skin blisters and severe itching. By measuring circulating antibody levels, the assay confirms clinical diagnoses, assesses disease activity, and assists healthcare providers in effectively monitoring how well a patient responds to ongoing immunosuppressive or anti-inflammatory treatment.

The BRCA 1/2 Germline Test is a specialized hereditary genetic assay designed to detect inherited mutations within the BRCA1 and BRCA2 genes.
Key aspects of this molecular test include:
* Sample Collection: Typically performed using a simple blood or saliva sample to extract constitutional DNA.
* Inherited Mutations: Identifies germline variants passed down from parents that significantly elevate lifetime risks for developing hereditary breast, ovarian, and related cancers.
* Clinical Utility: Empowers individuals and healthcare providers to implement proactive surveillance, preventive risk-reducing strategies, and targeted therapeutic options such as PARP inhibitors.

The bone profile B test is a specialized diagnostic blood panel used to evaluate skeletal metabolism, mineral balance, and bone turnover rates. This expanded assessment typically measures serum calcium, phosphate, alkaline phosphatase (ALP), albumin, and adjusted calcium levels, alongside extended metabolic markers.
By analyzing these biochemical components together, healthcare providers can assess how efficiently bones form and break down. The test is essential for identifying and monitoring systemic disorders such as hyperparathyroidism, Paget's disease, vitamin deficiencies, and renal-related bone mineral complications, ensuring targeted and effective clinical management.

The Bad Obstetric History (BOH) panel test is a comprehensive diagnostic blood evaluation recommended for women who have experienced recurrent pregnancy losses, such as consecutive spontaneous miscarriages, stillbirths, or early neonatal deaths.
This panel primarily investigates underlying medical triggers by screening for chronic infections—such as TORCH agents—autoimmune and blood-clotting disorders like antiphospholipid syndrome, and hormonal imbalances including thyroid dysfunction. By precisely identifying these root causes, healthcare providers can design targeted treatment plans to support safer, healthier outcomes in future pregnancies.

The Blood Toxic Element Profile Test is a comprehensive diagnostic panel designed to measure the levels of hazardous heavy metals and toxic substances circulating in the bloodstream. This specialized screening evaluates exposure to harmful elements such as lead, mercury, arsenic, cadmium, and aluminum, which can accumulate from environmental pollution, occupational hazards, or dietary sources. Elevated concentrations of these heavy metals can cause severe systemic damage affecting neurological, renal, and cardiovascular functions. By accurately quantifying these toxic loads, healthcare providers can identify acute or chronic poisoning, monitor detoxification treatments, and implement targeted interventions.

The beta-2 microglobulin (B2M) test measures the amount of a small protein found on the surface of most cells in your body. Small amounts naturally shed into your blood and urine, but high levels can mean certain cells are turning over too quickly or your immune system is working overtime. Doctors usually order this test to help diagnose, monitor, or check the severity of blood cancers like multiple myeloma, lymphoma, and certain leukemias. It can also help evaluate kidney damage or inflammatory conditions, giving your healthcare team important insights into your overall health and treatment progress.

A **Basic Arthritis Profile for Male** is a targeted blood panel designed to evaluate systemic inflammation and identify markers associated with various arthritic conditions. This profile typically includes tests such as Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) to detect generalized inflammatory responses, along with Rheumatoid Factor (RF) and sometimes Anti-CCP to screen for autoimmune joint diseases. Additionally, Uric Acid levels are frequently measured to assess for gout, a condition notably prevalent in men. By analyzing these specific biomarkers, healthcare providers can differentiate between inflammatory and non-inflammatory joint pain, facilitating an accurate diagnosis and timely intervention to preserve long-term joint health.